1776 Wealth’s Precigen PGEN Stock Holding History

1776 Wealth’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-700	Closed	-$3K	–	261
2020 Q2	$3K	Hold	700	–	–	﹤0.01%	313
2020 Q1	$2K	Hold	700	–	–	﹤0.01%	346
2019 Q4	$3K	Buy	+700	New	+$3.94K	﹤0.01%	314

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

1776 Wealth's PGEN Position: Q3 2020 in Review

1776 Wealth sold out of Precigen (PGEN) in Q3 2020, closing a stake of 700 shares — an estimated $3K sold.

1776 Wealth first reported a position in PGEN in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q2 2020. 159 funds tracked by Wall St. Rank hold PGEN as of Q3 2020.

1776 Wealth reported no remaining Precigen position as of Q3 2020 after selling out during the quarter.
1776 Wealth sold 700 Precigen shares in Q3 2020, an estimated $3K.
1776 Wealth first reported a position in Precigen in Q4 2019 and held it in 3 quarters.
1776 Wealth's Precigen position peaked at $3K in Q2 2020.
159 funds tracked by Wall St. Rank held Precigen as of Q3 2020.

Based on 1776 Wealth's 13F filing for Q3 2020, filed 12 Nov 2020.